Articoli correlati a Method Development and Validation: Montelukast as API...
Compra nuovo
Visualizza questo articolo
EUR 37,23
EUR 9,70 per la spedizione da Germania a Italia
Destinazione, tempi e costiRisultati della ricerca per Method Development and Validation: Montelukast as API...
Immagini fornite dal venditore
Method Development and Validation
Editore:
LAP Lambert Academic Publishing, 2023
ISBN 10: 6206765954
ISBN 13: 9786206765950
Nuovo
Brossura
Da: moluna, Greven, Germania
Valutazione del venditore 5 su 5 stelle
Condizione: New. Dieser Artikel ist ein Print on Demand Artikel und wird nach Ihrer Bestellung fuer Sie gedruckt. Montelukast: Method development and Validation deals with the development of a new simple, rapid, specific, accurate and precise UV spectrophotometric method for Active Pharmaceutical Ingredient (API) and in pharmaceutical dosage form. The validation of the. Codice articolo 1100749786
Quantità: Più di 20 disponibili
Immagini fornite dal venditore
Method Development and Validation
Editore:
LAP LAMBERT Academic Publishing Aug 2023, 2023
ISBN 10: 6206765954
ISBN 13: 9786206765950
Nuovo
Taschenbuch
Da: BuchWeltWeit Ludwig Meier e.K., Bergisch Gladbach, Germania
Valutazione del venditore 5 su 5 stelle
Taschenbuch. Condizione: Neu. This item is printed on demand - it takes 3-4 days longer - Neuware -Montelukast: Method development and Validation deals with the development of a new simple, rapid, specific, accurate and precise UV spectrophotometric method for Active Pharmaceutical Ingredient (API) and in pharmaceutical dosage form. The validation of the proposed method was carried out according to the I.C.H guidelines. Montelukast is a leukotriene receptor antagonist with anti-inflammatory and broncho-dilating activities. Having high affinity and selectivity for CysLT type 1 receptor it prevents any action at the receptor site from LTD4, LTE4 thus preventing allergic symptoms. Validation parameters covering all the qualitative and quantitative estimation of the drugs are mentioned along with the acceptance criteria as mentioned in the guidelines of the ICH. A simple and sensitive spectrophotometric method for montelukast as API and in pharmaceutical dosage form was developed. The new introduced method was found to be inexpensive, easy and reliable. The maximum absorbance for montelukast in methanol was found to be 270nm. The method was found to be progressive and behaves according to beers lamberts statute in concentration range of 5-45mig/ml for both the drugs. 52 pp. Englisch. Codice articolo 9786206765950
Quantità: 2 disponibili
Immagini fornite dal venditore
Method Development and Validation
Editore:
LAP LAMBERT Academic Publishing Aug 2023, 2023
ISBN 10: 6206765954
ISBN 13: 9786206765950
Nuovo
Taschenbuch
Da: buchversandmimpf2000, Emtmannsberg, BAYE, Germania
Valutazione del venditore 5 su 5 stelle
Taschenbuch. Condizione: Neu. Neuware -Montelukast: Method development and Validation deals with the development of a new simple, rapid, specific, accurate and precise UV spectrophotometric method for Active Pharmaceutical Ingredient (API) and in pharmaceutical dosage form. The validation of the proposed method was carried out according to the I.C.H guidelines. Montelukast is a leukotriene receptor antagonist with anti-inflammatory and broncho-dilating activities. Having high affinity and selectivity for CysLT type 1 receptor it prevents any action at the receptor site from LTD4, LTE4 thus preventing allergic symptoms. Validation parameters covering all the qualitative and quantitative estimation of the drugs are mentioned along with the acceptance criteria as mentioned in the guidelines of the ICH. A simple and sensitive spectrophotometric method for montelukast as API and in pharmaceutical dosage form was developed. The new introduced method was found to be inexpensive, easy and reliable. The maximum absorbance for montelukast in methanol was found to be 270nm. The method was found to be progressive and behaves according to beers lamberts statute in concentration range of 5-45¿g/ml for both the drugs.Books on Demand GmbH, Überseering 33, 22297 Hamburg 52 pp. Englisch. Codice articolo 9786206765950
Quantità: 2 disponibili
Immagini fornite dal venditore
Method Development and Validation : Montelukast as API and in Solid Dosage Form
Editore:
LAP LAMBERT Academic Publishing, 2023
ISBN 10: 6206765954
ISBN 13: 9786206765950
Nuovo
Taschenbuch
Da: AHA-BUCH GmbH, Einbeck, Germania
Valutazione del venditore 5 su 5 stelle
Taschenbuch. Condizione: Neu. nach der Bestellung gedruckt Neuware - Printed after ordering - Montelukast: Method development and Validation deals with the development of a new simple, rapid, specific, accurate and precise UV spectrophotometric method for Active Pharmaceutical Ingredient (API) and in pharmaceutical dosage form. The validation of the proposed method was carried out according to the I.C.H guidelines. Montelukast is a leukotriene receptor antagonist with anti-inflammatory and broncho-dilating activities. Having high affinity and selectivity for CysLT type 1 receptor it prevents any action at the receptor site from LTD4, LTE4 thus preventing allergic symptoms. Validation parameters covering all the qualitative and quantitative estimation of the drugs are mentioned along with the acceptance criteria as mentioned in the guidelines of the ICH. A simple and sensitive spectrophotometric method for montelukast as API and in pharmaceutical dosage form was developed. The new introduced method was found to be inexpensive, easy and reliable. The maximum absorbance for montelukast in methanol was found to be 270nm. The method was found to be progressive and behaves according to beers lamberts statute in concentration range of 5-45mig/ml for both the drugs. Codice articolo 9786206765950
Quantità: 1 disponibili